The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending more data on everyone else — raising questions about whether some ...

A first-of-its-kind treatment to slow the symptoms of early Alzheimer's disease has been approved for use in Australia.The Therapeutic Goods Administration has registered pharmaceutical giant Eli ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

The FDA will now require clinical trials to approve boosters for healthy Americans under 65, making it unlikely the shots ...

A new study has led to Health and Human Services Secretary Robert F. Kennedy, Jr. to order a “complete review” of the ...

The agency said it would approve new versions of the vaccine only for adults 65 years of age and older as well as for people with one or more risk factors for severe COVID-19 outcomes. These risk ...

Older adults can continue getting covid boosters, but not everyone who wants them can. You’re reading The Checkup With Dr.

The shift was a marked departure from previous FDA guidance, which recommended an annual COVID vaccine for everyone 6 months ...

Biotechs have faced several challenging years with slumping valuations and a competitive funding environment. However, the latest slew of ...

Blood and urine tests might be able to reveal how much of your diet is made up of industrially produced foods, a new study ...

Previously, updated COVID vaccines had been recommended annually by the CDC for everyone over the age of 6 months. The CDC has historically set vaccine recommendations, while the FDA determines which ...

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit future shots to older Americans and people at higher risk of serious Covid-19 ...